Since 1983, eight new AEDs have been introduced (see Table 2 below). Sadly, a recent VA study of more than 21,000 subjects aged 65 years and older revealed that 80% were being treated with ...
U.S. Rep. John Larson, D-1st District, suffered a “complex partial seizure” that caused him to freeze and abruptly stop speaking while delivering a floor speech on Monday, according to a statement ...
Rep. John Larson, D-Conn., said in a statement on Tuesday that a complex partial seizure was ruled as the cause of the episode where he paused during a House floor speech on Monday. While delivering ...
Axios Sneak Peek on MSN
Rep. John Larson says "partial seizure" caused him to freeze up during floor speech
Rep. John Larson (D-Conn.) said Tuesday that a "complex partial seizure" was what caused him to seize up during a House floor speech the previous day. Why it matters: The 76-year-old's office had ...
Connecticut Rep. John Larson says a complex partial seizure caused him to stop speech on House floor
WASHINGTON (AP) — Connecticut U.S. Rep. John Larson, who inexplicably stopped speaking during a speech Monday on the House of Representatives floor, said Tuesday night he had suffered a complex ...
CONNECTICUT (WTNH) — Rep. John Larson is thanking his supporters after he had a partial seizure Monday on the House floor, according to a press release from his team. On Tuesday night, Larson released ...
Forbes contributors publish independent expert analyses and insights. I focus on new drugs and innovations in medical devices. Last week, the FDA approved XCOPRI (cenobamate tablets) to treat ...
Rep. John Larson (D-CT) said he suffered a “complex partial seizure” Monday that caused his speech to stop abruptly on the House floor. Larson, 76, was in the middle of a floor speech when he stopped ...
Congressman John Larson appears to have had a medical episode while on the House floor Monday afternoon. In a statement, Larson said he had a "complex partial seizure" which caused a momentary pause ...
Treatment with vigabatrin carries the risk of permanent vision loss. The Food and Drug Administration (FDA) has expanded the approval of Sabril® (vigabatrin; Lundbeck) to include treatment of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results